Clinical trial
Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation…
NCT00003580 · University of Tennessee, Other · Completed
Key facts
| NCT number | NCT00003580 |
|---|---|
| Title | Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer |
| Official title | Phase II Study - Efficacy of Amifostine in Alleviating Toxicity Associated With Targeted Supradose Cisplatin and Concomitant Radiation Therapy (RADPLAT) in Head and Neck Cancer |
| Lead sponsor | University of Tennessee, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer, Oral Complications, Radiation Toxicity |
| Intervention type | Drug, Radiation |
| Interventions | amifostine trihydrate, cisplatin, radiation therapy |
| Start date | Jun 1, 1998 |
| Completion | May 1, 2004 |
| First posted | May 25, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: